Ultragenyx Pharmaceutical, Inc. (RARE)
Ultragenyx Pharmaceutical Revenue (Annual): 560.23M for Dec. 31, 2024
Revenue (Annual) Chart
Historical Data
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
Revenue (Annual) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 14.20B |
| Amicus Therapeutics, Inc. | 528.30M |
| Geron Corp. | 76.99M |
| Ionis Pharmaceuticals, Inc. | 705.14M |
| Vertex Pharmaceuticals, Inc. | 10.98B |